Total Payments
$14,664
2024 Payments
$904.12
Companies
55
Transactions
909
Medicare Patients
19,494
Medicare Billing
$937,012
Payment Breakdown by Category
Food & Beverage$13,117 (89.4%)
Consulting$1,540 (10.5%)
Education$7.12 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,117 | 907 | 89.4% |
| Consulting Fee | $1,540 | 1 | 10.5% |
| Education | $7.12 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $1,665 | 2 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,613 | 115 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,082 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,062 | 58 | $0 (2024) |
| Amgen Inc. | $980.15 | 78 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $773.03 | 61 | $0 (2024) |
| ABBVIE INC. | $696.24 | 56 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $688.04 | 44 | $0 (2022) |
| Novo Nordisk Inc | $641.85 | 49 | $0 (2024) |
| PFIZER INC. | $506.71 | 33 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $904.12 | 60 | Amgen Inc. ($197.40) |
| 2023 | $1,123 | 74 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($250.37) |
| 2022 | $1,461 | 96 | Ironwood Pharmaceuticals, Inc ($154.41) |
| 2021 | $1,793 | 133 | AbbVie Inc. ($204.06) |
| 2020 | $2,119 | 150 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($302.88) |
| 2019 | $2,104 | 153 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($410.09) |
| 2018 | $1,695 | 130 | Takeda Pharmaceuticals U.S.A., Inc. ($282.94) |
| 2017 | $3,465 | 113 | Celgene Corporation ($1,665) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 37 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Lower GI | ||||||
| 01/30/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Opioid Induced Constipation | ||||||
| 01/26/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Lower GI | ||||||
| 01/24/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: RESPIRATORY | ||||||
| 01/20/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 01/18/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug), FARXIGA, BEVESPI AEROSPHERE | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
| 01/17/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: RESPIRATORY | ||||||
| 01/05/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 3,886 | 8,334 | $234,438 | $185,519 |
| 2022 | 45 | 4,947 | 11,374 | $296,137 | $241,639 |
| 2021 | 50 | 5,127 | 11,715 | $319,992 | $260,789 |
| 2020 | 54 | 5,534 | 11,000 | $305,016 | $249,065 |
Total Patients
19,494
Total Services
42,423
Medicare Billing
$937,012
Procedure Codes
191
All Medicare Procedures & Services
191 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 434 | $62,673 | $47,544 | 75.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 484 | $50,535 | $36,358 | 71.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 148 | 255 | $7,793 | $7,398 | 94.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $7,600 | $7,394 | 97.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 30 | 126 | $9,746 | $7,288 | 74.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 152 | 340 | $6,144 | $5,596 | 91.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 101 | $6,741 | $4,945 | 73.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 77 | 122 | $5,206 | $4,935 | 94.8% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 149 | 300 | $5,294 | $4,791 | 90.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 152 | 318 | $4,771 | $4,248 | 89.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 151 | 312 | $4,654 | $4,093 | 88.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 153 | 380 | $4,644 | $3,933 | 84.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 143 | 252 | $4,184 | $3,725 | 89.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 143 | 253 | $4,107 | $3,646 | 88.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 152 | 388 | $3,290 | $3,220 | 97.9% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 30 | 170 | $4,101 | $3,079 | 75.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 152 | 336 | $3,563 | $2,970 | 83.4% |
| 83550 | Iron binding capacity | Office | 2023 | 151 | 318 | $3,274 | $2,725 | 83.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 146 | 281 | $3,212 | $2,675 | 83.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 150 | 329 | $3,021 | $2,504 | 82.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 43 | 86 | $2,413 | $2,175 | 90.1% |
| 83540 | Iron level | Office | 2023 | 152 | 318 | $2,580 | $2,016 | 78.1% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 142 | 280 | $2,530 | $1,977 | 78.1% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 149 | 306 | $2,514 | $1,952 | 77.7% |
| 83735 | Magnesium level | Office | 2023 | 147 | 294 | $2,489 | $1,932 | 77.6% |
About Ellen Vitievsky
Ellen Vitievsky is a Internal Medicine healthcare provider based in West New York, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366547135.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ellen Vitievsky has received a total of $14,664 in payments from pharmaceutical and medical device companies, with $904.12 received in 2024. These payments were reported across 909 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($13,117).
As a Medicare-enrolled provider, Vitievsky has provided services to 19,494 Medicare beneficiaries, totaling 42,423 services with total Medicare billing of $937,012. Data is available for 4 years (2020–2023), covering 191 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location West New York, NJ
- Active Since 09/14/2006
- Last Updated 02/16/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366547135
Products in Payments
- Otezla (Drug) $2,123
- XIFAXAN (Drug) $1,349
- TRELEGY ELLIPTA (Drug) $730.16
- FARXIGA (Drug) $473.93
- Vascepa (Drug) $456.89
- Amitiza (Drug) $456.10
- Ozempic (Drug) $445.16
- Linzess (Drug) $359.50
- TRULANCE (Drug) $351.46
- LONHALA MAGNAIR (Drug) $342.51
- Entyvio (Biological) $272.81
- Yupelri (Drug) $267.33
- UBRELVY (Drug) $250.59
- LYRICA (Drug) $248.70
- SYMBICORT (Drug) $246.54
- BREZTRI (Drug) $237.51
- SOLIQUA 100/33 (Biological) $234.08
- ANORO (Drug) $226.66
- LINZESS (Drug) $225.62
- ZTLido (Drug) $221.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West New York
Dr. Agustin Diaz, Md, MD
Internal Medicine — Payments: $23,765
Internal Medicine $23,765
Ms. Monica Barrientos, Md, MD
Internal Medicine — Payments: $5,734
Internal Medicine $5,734
Dr. Rafael Latorre, M.d, M.D
Internal Medicine — Payments: $2,811
Internal Medicine $2,811
Dr. Jorge Figueroa, Md, MD
Internal Medicine — Payments: $2,773
Internal Medicine $2,773
Dr. Dennis Aponte, Md, MD
Internal Medicine — Payments: $2,493
Internal Medicine $2,493
Laura Torres Cruz, Md, MD
Internal Medicine — Payments: $1,058
Internal Medicine $1,058